Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
LATANOPROST
Actavis Group PTC ehf
S01EE01
LATANOPROST
50 Microgram/ML
Eye Drops Solution
Product subject to prescription which may not be renewed (A)
Prostaglandin analogues
Authorised
2014-02-21
PACKAGE LEAFLET: INFORMATION FOR THE USER Proxal 50 micrograms/ml eye drops, solution Latanoprost READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or the doctor treating your child or pharmacist. - This medicine has been prescribed for you or for your child only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or the doctor treating your child or pharmacist. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET 1. What Proxal is and what it is used for 2. What you need to know before you use Proxal 3. How to use Proxal 4. Possible side effects 5. How to store Proxal 6. Contents of the pack and other information 1. WHAT PROXAL IS AND WHAT IT IS USED FOR Proxal belongs to a group of medicines known as prostaglandin analogues. It works by increasing the natural outflow of fluid from inside the eye into the bloodstream. Proxal is used to treat conditions known as OPEN ANGLE GLAUCOMA and OCULAR HYPERTENSION. Both of these conditions are linked with an increase in the pressure within your eye, eventually affecting your eye sight. Proxal is also used to treat increased eye pressure and glaucoma in all ages of children and babies. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE PROXAL Proxal can be used in adult men and women (including the elderly) and in children from birth to 18 years of age. Proxal has/have not been investigated in prematurely born infants (less than 36 weeks gestation). . DO NOT USE PROXAL Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Proxal 50 micrograms/ml eye drops, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of eye drop contains 50 micrograms of latanoprost. 2.5 ml bottle of eye drops contains 125 micrograms of latanoprost. Excipient with known effect: 0.2 mg benzalkonium chloride/ml eye drops. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops, solution (eye drops). A clear colourless solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension. Reduction of elevated intraocular pressure in paediatric patients with elevated intraocular pressure and paediatric glaucoma. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Recommended dosage for adults (including older people):_ Recommended therapy is one eye drop in the affected eye(s) once daily. Optimal effect is obtained if Proxal is administered in the evening. The dosage of Proxal should not exceed once daily since it has been shown that more frequent administration decreases the intraocular pressure lowering effect. If one dose is missed, treatment should continue with the next dose as normal. Method of administration As with any eye drops, to reduce possible systemic absorption, it is recommended that the lachrymal sac be compressed at the medial canthus (punctal occlusion) for one minute. This should be performed immediately following the instillation of each drop. Contact lenses should be removed before instillation of the eye drops and may be reinserted after 15 minutes. If more than one topical ophthalmic medicinal product is being used, the medicinal products should be administered at least five minutes apart. HEALTH PRODUCTS REGULATORY A Read the complete document